When cells get stressed: An integrative view of cellular senescence

Journal of Clinical Investigation

Volumn 113, Issue 1, 2004, Pages 8-13

  Ben Porath, Ittai ^a   Weinberg, Robert A ^a  

^a WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL DNA; TELOMERASE;

AGING; CARCINOGENESIS; CELL AGING; CELL CYCLE; CELL DIVISION; CELL FUNCTION; CELL GROWTH; CELL POPULATION; CELL PROLIFERATION; CELL STRUCTURE; CHROMATIN STRUCTURE; DNA DAMAGE; HUMAN; IN VIVO STUDY; MOLECULAR BIOLOGY; NONHUMAN; PRIORITY JOURNAL; REVIEW; STRESS; TELOMERE; ANIMAL; BIOLOGICAL MODEL; GENETICS; PHYSIOLOGY; TUMOR SUPPRESSOR GENE;

ANIMALS; CELL AGING; CELL CYCLE; CELL DIVISION; GENES, TUMOR SUPPRESSOR; HUMANS; MODELS, BIOLOGICAL; MODELS, GENETIC; TELOMERE;

EID: 1542781659     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI200420663     Document Type: Review

References (56)

1. Hayflick, L., and Moorhead, P.S. 1961. The serial cultivation of human diploid cell strains. Exp. Cell Res. 25:585-621.
2. Campisi, J. 2000. Cancer, aging and cellular senescence. In Vivo. 14:183-188.
3. Sitte, N., Merker, K., Von Zglinicki, T., Grune, T., and Davies, K.J. 2000. Protein oxidation and degradation during cellular senescence of human BJ fibroblasts. I. Effects of proliferative senescence. FASEB J. 14:2495-2502.
4. Narita, M., et al. 2003. Rb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence. Cell. 113:703-716.
5. Lloyd, A.C. 2002. Limits to lifespan. Nat. Cell Biol. 4:E25-E27.
6. Donehower, L.A., et al. 1992. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature. 356:215-221.
7. Jacks, T., et al. 1992. Effects of an Rb mutation in the mouse. Nature. 359:295-300.
8. Krimpenfort, P., Quon, K.C., Mooi, W.J., Loonstra, A., and Berns, A. 2001. Loss of p16Ink4a confers susceptibility to metastatic melanoma in mice. Nature. 413:83-86.
9. Sharpless, N.E., et al. 2001. Loss of p16Ink4a with retention of p19Arf predisposes mice to tumorigenesis. Nature. 413:86-91.
10. Sherr, C.J., and DePinho, R.A. 2000. Cellular senescence: mitotic clock or culture shock? Cell. 102:407-410.
11. Wright, W.E., and Shay, J.W. 2002. Historical claims and current interpretations of replicative aging. Nat. Biotechnol. 20:682-688.
12. Satyanarayana, A., et al. 2003. Telomere shortening impairs organ regeneration by inhibiting cell cycle re-entry of a subpopulation of cells. EMBO J. 22:4003-4013.
13. Schmitt, C.A., et al. 2002. A senescence program controlled by p53 and p16INK4a contributes to the outcome of cancer therapy. Cell. 109:335-346.
14. Hayflick, L. 1998. How and why we age. Exp. Gerontol. 33:639-653.
15. Hatley, C.B., Futcher, A.B., and Greider, C.W. 1990. Telomeres shorten during ageing of human fibroblasts. Nature. 345:458-460.
16. Bodnar, A.G., et al. 1998. Extension of life-span by introduction of telomerase into normal human cells. Science. 279:349-352.
17. Vaziri, H., and Benchimol, S. 1998. Reconstitution of telomerase activity in normal human cells leads to elongation of telomeres and extended replicative life span. Curr. Biol. 8:279-282.
18. Fairweather, D.S., Fox, M., and Margison, G.P. 1987. The in vitro lifespan of MRC-5 cells is shortened by 5-azacytidine-induced demethylation. Exp. Cell Res. 168:153-159.
19. Chen, Q., and Ames, B.N. 1994. Senescence-like growth arrest induced by hydrogen peroxide in human diploid fibroblast F65 cells. Proc. Natl. Acad. Sci. U. S. A 91:4130-4134.
20. Venable, M. E., Lee, J.Y., Smyth, M.J., Bielawska, A., and Obeid, L.M. 1995. Role of ceramide in cellular senescence. J. Biol. Chem. 270:30701-30708.
21. Serrano, M., Lin, A.W., McCurrach, M.E., Beach, D., and Lowe, S.W. 1997. Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell. 88:593-602.
22. Robles, S.J., and Adami, G.R. 1998. Agents that cause DNA double strand breaks lead to p16INK4a enrichment and the premature senescence of normal fibroblasts. Oncogene. 16:1113-1123.
23. Wei, S., and Sedivy, J.M. 1999. Expression of catalytically active telomerase does not prevent premature senescence caused by overexpression of oncogenic Ha-Ras in normal human fibroblasts. Cancer Res. 59:1539-1543.
24. Gotbunova, V., Seluanov, A., and Pereira-Smith, O.M. 2002. Expression of human telomerase (hTERT) does not prevent stress-induced senescence in normal human fibroblasts but protects the cells from stress-induced apoptosis and necrosis. J. Biol. Chem. 277:38540-38549.
25. Wright, W.E., and Shay, J.W. 2000. Telomere dynamics in cancer progression and prevention: fundamental differences in human and mouse telomere biology. Nat. Med. 6:849-851.
26. Ramirez, R.D., et al. 2001. Putative telomere-independent mechanisms of replicative aging reflect inadequate growth conditions. Genes Dev. 15:398-403.
27. Herbert, B.S., Wright, W.E., and Shay, J.W. 2002. p16(INK4a) inactivation is not required to immortalize human mammary epithelial cells. Oncogene. 21:7897-7900.
28. Parrinello, S., et al. 2003. Oxygen sensitivity severely limits the replicative lifespan of murine fibroblasts. Nat. Cell Biol. 5:741-747.
29. Packer, L., and Fuehr, K. 1977. Low oxygen concentration extends the lifespan of cultured human diploid cells. Nature. 267:423-425.
30. Chen, Q., Fischer, A., Reagan, J.D., Yan, L.J., and Ames, B.N. 1995. Oxidative DNA damage and senescence of human diploid fibroblast cells. Proc. Natl. Acad. Sci. U. S. A. 92:4337-4341.
31. von Zglinicki, T., Saretzki, G., Docke, W., and Lotze, C. 1995. Mild hyperoxia shortens telomeres and inhibits proliferation of fibroblasts: a model for senescence? Exp. Cell Res. 220:186-193.
32. Forsyth, N.R., Evans, A.P., Shay, J.W., and Wright, W.E. 2003. Developmental differences in the immortalization of lung fibroblasts by telomerase. Aging Cell. 2:235-243.
33. Beausejour, C.M., et al. 2003. Reversal of human cellular senescence: roles of the p53 and p16 pathways. EMBO J. 22:4212-4222.
34. Itahana, K., et al. 2003. Control of the replicative life span of human fibroblasts by p16 and the polycomb protein Bmi-1. Mol. Cell. Biol. 23:389-401.
35. Wei, W., Herbig, U., Wei, S., Dutriaux, A., and Sedivy, J.M. 2003. Loss of retinoblastoma but not p16 function allows bypass of replicative senescence in human fibroblasts. EMBO Rep. 4:1061-1065.
36. Allsopp, R.C., and Harley, C.B. 1995. Evidence for a critical telomere length in senescent human fibroblasts. Exp. Cell Res. 219:130-136.
37. Shay, J.W., Pereira-Smith, O.M., and Wright, W.E. 1991. A role for both RB and p53 in the regulation of human cellular senescence. Exp. Cell Res. 196:33-39.
38. Harley, C.B., Vaziri, H., Counter, C.M., and Allsopp, R.C. 1992. The telomere hypothesis of cellular aging. Exp. Gerontol. 27:375-382.
39. d'Adda di Fagagna, F., et al. 2003. A DNA damage checkpoint response in telomere-initiated senescence. Nature. 426:194-198.
40. Martens, U.M., Chavez, E.A., Poon, S.S., Schmoor, C., and Lansdorp, P.M. 2000. Accumulation of short telomeres in human fibroblasts prior to replicative senescence. Exp. Cell Res. 256:291-299.
41. Baird, D.M., Rowson, J., Wynford-Thomas, D., and Kipling D. 2003. Extensive allelic variation and ultrashort telomeres in senescent human cells. Nat. Genet. 33:203-207.
42. Blackburn, E.H. 2000. Telomere states and cell fates. Nature. 408:53-56.
43. Rubin, H. 2002. The disparity between human cell senescence in vitro and lifelong replication in vivo. Nat. Biotechnol. 20:675-681.
44. Zhu, J., Wang, H., Bishop, J.M., and Blackburn, E.H. 1999. Telomerase extends the lifespan of virus-transformed human cells without net telomere lengthening. Proc. Natl. Acad. Sci. U. S. A. 96:3723-3728.
45. Karlseder, J., Smogorzewska, A., and de Lange, T. 2002. Senescence induced by altered telomere state, not telomere loss. Science. 295:2446-2449.
46. Blackburn, E.H. 2001. Switching and signaling at the telomere. Cell. 106:661-673.
47. McElligott, R., and Wellinger, R.J. 1997. The terminal DNA structure of mammalian chromosomes. EMBO J. 16:3705-3714.
48. Wellinger, R.J., and Sen, D. 1997. The DNA structures at the ends of eukaryotic chromosomes. Eur. J. Cancer 33:735-749.
49. Wright, W.E., Tesmer, V.M., Huffman, K.E., Levene, S.D., and Shay, J.W. 1997. Normal human chromosomes have long G-rich telomeric overhangs at one end. Genes Dev. 11:2801-2809.
50. Griffith, J.D., et al. 1999. Mammalian telomeres end in a large duplex loop. Cell. 97:503-514.
51. Cimino-Reale, G., et al. 2001. The length of telomeric G-rich strand 3′-overhang measured by oligonucleotide ligation assay. Nucleic Acids Res. 29:E35.
52. Stewart, S.A., et al. 2003. Erosion of the telomeric single-strand overhang at replicative senescence. Nat. Genet. 33:492-496.
53. van Steensel, B., Smogorzewska, A., and de Lange, T. 1998. TRF2 protects human telomeres from end-to-end fusion. Cell. 92:401-413.
54. Takai, H., Smogorzewska, A., and de Lange, T. 2003. DNA damage foci at dysfunctional telomeres. Curr. Biol. 13:1549-1556.
55. Smogorzewska, A., and de Lange, T. 2002. Different telomere damage signaling pathways in human and mouse cells. EMBO J. 21:4338-4348.
56. Masutomi, K., et al. 2000. Telomerase maintains telomere structure in normal human cells. Cell. 114:241-253.